Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer

This study has been withdrawn prior to enrollment.
(Not reached the statistical hypothesis at the interim analysis)
Sponsor:
Collaborator:
University Hospital of Crete
Information provided by:
Hellenic Oncology Research Group
ClinicalTrials.gov Identifier:
NCT00694200
First received: June 6, 2008
Last updated: December 14, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)